Rejection, Transplant Completed Phase 2 Trials for Bortezomib (DB00188)

Back to Rejection, Transplant

Also known as: Graft Rejection / Transplant rejections / Transplant Rejection / Transplanted organ rejection (disorder) / Graft rejection (finding) / Complication of transplanted organ (disorder)

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00771875Randomized Trial for Mixed Acute RejectionTreatment